glp-1 for alcohol use disorder Emerging pharmacological targets Semaglutide Shows Promise as a
Description
the Young Innovator Association of CAS (H.M.)
Sleep quality can be affected by both the autoimmune condition and, at higher doses, by GLP-1 therapy itself
What current evidence tells us is clear: GLP-1 medications demonstrate greater average outcomes at studied therapeutic doses
doi: 10.1016/j.amjmed.2015.07.015
